Stefania Sarno

Overview

Best Publications

• The Formation of Human Populations in South and Central Asia

  Vagheesh M. Narasimhan;Nick Patterson;Nick Patterson;Priya Moorjani;Nadin Rohland;Nadin Rohland

  785
  Citations

• Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

  Stefania Sarno;Helen Reddy;Flavio Meggio;Maria Ruzzene

  437
  Citations

• Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

  G Di Maira;M Salvi;G Arrigoni;O Marin

  395
  Citations

• The Protein Kinase CK2 Facilitates Repair of Chromosomal DNA Single-Strand Breaks

  Joanna I. Loizou;Sherif F. El-Khamisy;Anastasia Zlatanou;David J. Moore

  369
  Citations

• The selectivity of inhibitors of protein kinase CK2: an update.

  Mario A Pagano;Jenny Bain;Zygmunt Kazimierczuk;Stefania Sarno

  288
  Citations

• Toward the rational design of protein kinase casein kinase-2 inhibitors.

  Stefania Sarno;Stefano Moro;Flavio Meggio;Giuseppe Zagotto

  225
  Citations

• Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

  Mario A Pagano;Mariola Andrzejewska;Maria Ruzzene;Stefania Sarno

  224
  Citations

• Protein kinase CK2: a potential therapeutic target for diverse human diseases.

  Christian Borgo;Claudio D'Amore;Stefania Sarno;Mauro Salvi

  224
  Citations

• Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.

  Mauro Salvi;Stefania Sarno;Luca Cesaro;Hideji Nakamura

  220
  Citations

• Structural features underlying selective inhibition of protein kinase CK2 by ATP site‐directed tetrabromo‐2‐benzotriazole

  Roberto Battistutta;Erika De Moliner;Stefania Sarno;Giuseppe Zanotti

  211
  Citations

• The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.

  Roberto Battistutta;Stefania Sarno;Erika De Moliner;Elena Papinutto

  195
  Citations

• Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.

  Giorgio Cozza;Paolo Bonvini;Elisa Zorzi;Giorgia Poletto

  192
  Citations

• QUINALIZARIN AS A POTENT, SELECTIVE AND CELL PERMEABLE INHIBITOR OF PROTEIN KINASE CK2.

  Giorgio Cozza;Marco Mazzorana;Elena Papinutto;Jenny Bain

  190
  Citations

• Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.

  Roberto Battistutta;Giorgio Cozza;Fabrice Pierre;Elena Papinutto

  184
  Citations

• Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight.

  Graziano Lolli;Giorgio Cozza;Marco Mazzorana;Elena Tibaldi

  175
  Citations

• Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

  Stefania Sarno;Erika De Moliner;Maria Ruzzene;Mario A. Pagano

  172
  Citations

• Protein Kinase CK2 Mutants Defective in Substrate Recognition PURIFICATION AND KINETIC ANALYSIS

  S. Sarno;P. Vaglio;F. Meggio;O.-G. Issinger

  158
  Citations

• Inspecting the Structure-Activity Relationship of Protein Kinase CK2 Inhibitors Derived from Tetrabromo-Benzimidazole

  Roberto Battistutta;Marco Mazzorana;Stefania Sarno;Zygmunt Kazimierczuk

  151
  Citations

• Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors.

  Mario A. Pagano;Giorgia Poletto;Giovanni Di Maira;Giorgio Cozza

  148
  Citations

• Protein kinase CK2 as a druggable target

  Stefania Sarno;Lorenzo A. Pinna

  146
  Citations